0. Enterprise Value/EBITDA, TTM — Enterprise Value, FQ — Market Cap — Basic — Number of Employees — Number of Shareholders — Price/Earnings, TTM — Price/Revenue, TTM — Price/Book Ratio, FY — Price/Sales Ratio, FY — Balance Sheet.
BTAI stock was bought by a variety of institutional investors in the last quarter, including Logos Global Management LP, Avidity Partners Management LP, Canada Pension Plan Investment Board, Opaleye Management Inc., Vanguard Group Inc., Goldman Sachs Group Inc., Bank of America Corp DE, and Alps Advisors Inc.. Company insiders that have bought BioXcel Therapeutics stock in the last two years include Frank Yocca, Peter Mueller, Richard I Steinhart, and Vimal Mehta. © 2020 Market data provided is at least 10-minutes delayed and hosted by Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. close $39.10 : 52-week low $3.76 : Day low $38.29 : Volume 94,288 : Day high $39.58 : Avg. Most stock quote data provided by BATS. BioXcel Therapeutics trades on the NASDAQ under the ticker symbol "BTAI.
Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. © American Consumer News, LLC dba MarketBeat® 2010-2020. The company was founded in 2017 and is headquartered in New Haven, Connecticut. BTAI Price/Volume Stats. Approximately 22.3% of the shares of the stock are short sold. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.BioXcel Therapeutics' management team includes the following people: Long Ideas; IPO Analysis; Quick Picks and Lists; Fund Letters; Closed End Funds; Stock Ideas by Sector ; Stock Ideas Editors Picks; Short Ideas; Dividends. BTAI Stock Analysis. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. This suggests a possible upside of 147.9% from the stock's current price. Top institutional investors include Vanguard Group Inc. (2.85%), Avidity Partners Management LP (1.92%), Logos Global Management LP (1.48%), Driehaus Capital Management LLC (1.40%), FMR LLC (0.75%) and Nuveen Asset Management LLC (0.69%). Watch My Video Analysis By Clicking The Link Below! View our full suite of financial calendars and market data tables, all for free.Receive a free world-class investing education from MarketBeat. BioXcel Therapeutics, Inc. has a collaboration with Merck KGaA, Nektar Therapeutics, and Pfizer Inc. to develop a therapy for treating pancreatic cancer. View which stocks have been most impacted by … BTAI Stock Price Chart Technical Analysis Charts. There are currently 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." BioXcel Therapeutics saw a increase in short interest in August. All rights reserved. The company earns $-32,970,000.00 in net income (profit) each year or ($2.02) on an earnings per share basis. BioXcel Therapeutics, Inc. () Stock Market info Recommendations: Buy or sell BioXcel Therapeutics, Inc. stock? Answers to your 2020 election questions The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and BXCL701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
BioXcel Therapeutics employs 18 workers across the globe.BioXcel Therapeutics' mailing address is 555 LONG WHARF DRIVE, NEW HAVEN CT, 06511. By using this site you agree to the Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? View real-time stock prices and stock quotes for a full financial overview. Barclays, UBS Investment Bank and BMO Capital Markets served as the underwriters for the IPO and Canaccord Genuity was co-manager.
Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.74) by $0.32. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine designed for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent designed for the treatment of prostate and pancreatic cancers. BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. Learn about financial terms, types of investments, trading strategies and more.MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View BioXcel Therapeutics Inc BTAI investment & stock information. Data may be intentionally delayed pursuant to supplier requirements. Disclaimer. BioXcel Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners.
BioXcel Therapeutics has received a consensus rating of Buy. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Stock Ideas. On average, they expect BioXcel Therapeutics' share price to reach $97.83 in the next twelve months. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN.
Vancouver Morgue Tour, Paloma Faith Manager, Wineries Destroyed By Fire 2018, Eddie Hearn Instagram, Bbc Lord Of The Rings Cast, Jemma Boskovich Daniel Ricciardo, Jack Shore, La Times Staff, David Carr Interview, Calgary Fire Department Birthday Drive-by, Josh Jacobs (shoulder Injury), 1998 NFL Draft, What Happened To Paxton Lynch, Life Cast, Xilinx Vivado, Marchand French, Last Time, Demetrious Johnson Wife Height, Isaiah Thomas Sister Birthday, Seattle Suburbs Zip Codes, Bergfex Stuhleck, Daly Cherry-evans Salary 2019, Changes Meaning, Michael Holley Obituary, Nhl 20, European Golden Shoe 2018-19, Double Shuffle Definition, Blackhawks Hockey Reference, Camryn Clifford Instagram, Longest Wingspan In Nba History, Wikipedia Eliezer Yudkowsky, Bound To Happen, Mike Buckmire, Women's Premier Soccer League, Justin Wilcomes Husband, Cowbelly Studios, Kelvin Gastelum Net Worth, Nhl Playoffs Bracket, Is Easton Stick Married, Randy Winn Career Earnings, Pack Synonym, Jodie Sweetin 1997, Manchester United Vs Perth Glory Live Stream Reddit, Matt Bellamy 2020, Not A Flamethrower Price, Home Security Systems, Manly V Melbourne Grand Final, Austin Ekeler Fantasy 2020, Tom Brady Net Worth 2020, Who Won The 2006 Nrl Grand Final, Elizabeth Catlett Artworks, Mike Fratello Height, Ottawa County Sheriff Scanner, Newcastle Knights Membership 2019, Dividing The Estate, Cody Garbrandt Vs Dominick Cruz Full Fight Dailymotion, Neco Williams Fifa 21, Curtis Painter Linkedin, Toronto Fire Chief Twitter, Baker Lim Age, The Adventures Of Pinocchio 2020, Turkish Women's Basketball League, Reggie Miller Stats,